IRTC iRhythm Technologies
WatchlistiRhythm Technologies News
Derrick Sung Joins Aerin Medical as Chief Financial Officer
Is IRhythm Technologies, Inc. (NASDAQ:IRTC) Trading At A 44% Discount?
Key Insights The projected fair value for iRhythm Technologies is US$147 based on 2 Stage Free Cash Flow to Equity iRhythm Technologies' US$81.60 share price signals that it might be 44% undervalued
New Research Presented at American Heart Association's 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization
SAN FRANCISCO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the results of a new retrospective analysis, conducted in partnership with Duke Health, that found incorporating
Truist Financial Remains a Buy on Irhythm Technologies (IRTC)
What 4 Analyst Ratings Have To Say About IRhythm Technologies
Within the last quarter, iRhythm Technologies (NASDAQ:IRTC) has observed the following analyst ratings: BullishSomewhat BullishIndifferentSomewhat BearishBearishTotal Ratings31000Last 30D100001M Ago01
Positive Outlook for Irhythm Technologies: Resolving Regulatory Issues, Revenue Growth and Future Prospects Despite Comp Group Multiple Compression
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Irhythm Technologies (IRTC) and Definitive Healthcare Corp (DH)
Needham Maintains Buy on IRhythm Technologies, Lowers Price Target to $108
Needham analyst David Saxon maintains iRhythm Technologies (NASDAQ:IRTC) with a Buy and lowers the price target from $140 to $108.
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Irhythm Technologies (IRTC) and Seres Therapeutics (MCRB)
IRhythm Technologies Inc (IRTC) Reports 20% Revenue Growth in Q3 2023
IRhythm Technologies GAAP EPS of -$0.89 Misses by $0.22, Revenue of $124.6M Beats by $2.03M
IRhythm Technologies Q3 2023 Earnings Preview
Down -23.87% in 4 Weeks, Here's Why IRhythm Technologies (IRTC) Looks Ripe for a Turnaround
IRhythm Technologies Insiders Sell US$4.0m Of Stock, Possibly Signalling Caution
Over the past year, many iRhythm Technologies, Inc. (NASDAQ:IRTC) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is u
Express News | Shares of Healthcare Equipment and Tools Stocks Are Trading Lower in Sympathy With Thermo Fisher and Danaher
IRhythm Technologies to Report Third Quarter 2023 Financial Results on November 2, 2023
SAN FRANCISCO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today
Irhythm Technologies (IRTC) Gets a Buy From BTIG
Morgan Stanley Maintains Overweight on IRhythm Technologies, Lowers Price Target to $135
Morgan Stanley analyst Cecilia Furlong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and lowers the price target from $149 to $135.
Buy Rating Maintained for Irhythm Technologies Amidst Anticipated Q4 Surge Post-ZioMonitor Product Launch
IRhythm Technologies (NASDAQ:IRTC Investor Three-year Losses Grow to 65% as the Stock Sheds US$304m This Past Week
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But long term iRhythm Technologies, Inc. (NASDAQ:IRTC) shareholders have had a parti